Telix Pharmaceuticals Sees Major Shareholder Exit

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

State Street Global Advisors has ceased to be a substantial holder in Telix Pharmaceuticals Limited as of August 20, 2024. The details of the change, including the nature of the change and voting securities affected, were formalized through a notice that was provided to the company. This marks a significant shift in the company’s shareholder structure, which may interest investors and market watchers.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.